Activation of T cells in preterm infants with respiratory distress syndrome

Neonatology

Volumn 96, Issue 4, 2009, Pages 248-258

  Turunen, Riikka ^a,c   Vaarala, Outi ^d   Nupponen, Irmeli ^b,c   Kajantie, Eero ^b,d   Siitonen, Sanna ^e   Lano, Aulikki ^b   Repo, Heikki ^c,e   Andersson, Sture ^b  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bronchopulmonary dysplasia; Lymphocytes; Mechanical ventilation; Respiratory distress syndrome; Systemic inflammation

Indexed keywords

AMPICILLIN; BETAMETHASONE; CELL ADHESION MOLECULE; DOBUTAMINE; DOPAMINE; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; NETILMICIN; PLACEBO; PORACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HYPOTENSION; INFANT; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG DYSPLASIA; MALE; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CD4 LYMPHOCYTE COUNT; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; LYMPHOCYTE ACTIVATION; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; T-LYMPHOCYTES;

EID: 66049083137     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000220764     Document Type: Article

References (48)

1. Jobe AH, Ikegami M: Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998; 53: 81-94.
2. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shapiro DL: Newborn tracheal aspirate cytology: Classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 1981; 98: 949-956.
3. Merritt TA, Puccia JM, Stuard ID: Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and bronchopulmonary dysplasia. Acta Cytol 1981; 25: 631-639.
4. Murch SH, Costeloe K, Klein NJ, McDonald TT: Early production of macrophage inflammatory protein-1α occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 1996; 40: 490-497.
5. Murch SH, Costeloe K, Klein NJ, Rees H, McIntosh N, Keeling JW, MacDonald TT: Mucosal tumor necrosis factor-α production and extensive disruption of sulfated glycosaminoglycans begin within hours of birth in neonatal respiratory distress syndrome. Pediatr Res 1996; 40: 484-489.
6. Speer CP, Ruess D, Harms K, Herting E, Gefeller O: Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 1993; 91: 794-799.
7. Brus F, van Oeveren W, Okken A, Bambang SO: Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1996; 39: 456-463.
8. Brus F, van Oeveren W, Okken A, Oetomo SB: Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity. Pediatrics 1997; 99: 672-680.
9. Nupponen I, Pesonen E, Andersson S, Makela A, Turunen R, Kautiainen H, Repo H: Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002; 110: 36-41.
10. Sveger T, Ohlsson K, Morse H, Polberger S, Laurin S: Plasma neutrophil lipocalin, elastase- alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest 2003; 63: 89-92.
11. Turunen R, Nupponen I, Siitonen S, Repo H, Andersson S: Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Pediatrics 2006; 117: 448-454.
12. Hillman NH, Moss TJ, Kallapur SG, Bachurski C, Pillow JJ, Polglase GR, Nitsos I, Kramer BW, Jobe A: Brief, large tidal volume ventilation initiates lung injury and systemic response in fetal sheep. Am J Respir Crit Care Med 2007; 176: 575-581.
13. Speer CP: Inflammation and bronchopulmonary dysplasia: A continuing story. Semin Fetal Neonatal Med 2006; 11: 354-362.
14. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
15. Dammann O, Leviton A, Gappa M, Dammann CE: Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/ inflammation and long term outcome. BJOG 2005; 112: 4S-9S.
16. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M: Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992; 13: 215-218.
17. Stanciu LA, Djukanovic R: The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur Respir J 1998; 11: 949-957.
18. Chirathaworn C, Kohlmeier JE, Tibbetts SA, Rumsey LM, Chan MA, Benedict SH: Stimulation through intercellular adhesion molecule- 1 provides a second signal for T cell activation. J Immunol 2002; 168: 5530-5537.
19. Springer TA: Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
20. Lub M, van Kooyk Y, Figdor CG: Ins and outs of LFA-1. Immunol Today 1995; 16: 479-483.
21. Picker LJ, Butcher EC: Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992; 10: 561-591.
22. Hoebe K, Janssen E, Beutler B: The interface between innate and adaptive immunity. Nat Immunol 2004; 5: 971-974.
23. Vivier E, Malissen B: Innate and adaptive immunity: Specificities and signaling hierarchies revisited. Nat Immunol 2005; 6: 17-21.
24. Lanzavecchia A, Sallusto F: From synapses to immunological memory: The role of sustained T cell stimulation. Curr Opin Immunol 2000; 12: 92-98.
25. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213-1222.
26. Leviton A, Dammann O, Durum SK: The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol 2005; 58: 821-828.
27. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M: Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr 2005; 146: 632-637.
28. Pihkala J, Hakala T, Voutilainen P, Raivio K: Characteristic of recent fetal growth curves in Finland. Duodecim 1989; 105: 1540-1546.
29. Kajantie E, Raivio T, Janne OA, Hovi P, Dunkel L, Andersson S: Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment. J Clin Endocrinol Metab 2004; 89: 3999-4003.
30. Touwen BCL: Neurological Development in Infancy. Cambridge, Cambridge University Press, 1976.
31. Brandt I, Sticker E: Griffiths Entwicklungsskalen zur Beurteilung der Entwicklung in den ersten beiden Lebensjahren. Göttingen, Beltz Test, 2001.
32. Bayley N: Bayley Scales of Infant Development, ed 2 (BSID-II). San Antonio, Harcourt Brace & Co, 1993.
33. Matzinger P: The danger model: A renewed sense of self. Science 2002; 296: 301-305.
34. Gett AV, Sallusto F, Lanzavecchia A, Geginat J: T cell fitness determined by signal strength. Nat Immunol 2003; 4: 355-360.
35. Hammerschmidt S, Kuhn H, Sack U, Schlenska A, Gessner C, Gillissen A, Wirtz H: Mechanical stretch alters alveolar type II cell mediator release toward a proinflammatory pattern. Am J Respir Cell Mol Biol 2005; 33: 203-210.
36. Rosen D, Lee JH, Cuttitta F, Rafiqi F, Degan S, Sunday ME: Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2006; 174: 75-83.
37. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drenou B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18: 487-494.
38. Vreugdenhil HA, Lachmann B, Haitsma JJ, Zijlstra J, Heijnen CJ, Jansen NJ, van Vught AJ: Exogenous surfactant restores lung function but not peripheral immunosuppression in ventilated surfactant-deficient rats. Exp Lung Res 2006; 32: 1-14.
39. Crowley P: Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2008; 3:CD000065.
40. Kramer BW: Antenatal inflammation and lung injury: Prenatal origin of neonatal disease. J Perinatol 2008; 28:S21-S27.
41. Ballabh P, Simm M, Kumari J, Krauss AN, Jain A, Auld PA, Cunningham-Rundles S: Lymphocyte subpopulations in bronchopulmonary dysplasia. Am J Perinatol 2003; 20: 465-475.
42. Watterberg K: Anti-inflammatory therapy in the neonatal intensive care unit: Present and future. Semin Fetal Neonatal Med 2006; 11: 378-384.
43. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215.
44. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM: Risk factors for chronic lung disease in the surfactant era: A North Carolina population-based study of very low birth weight infants. Pediatrics 1999; 104: 1345-1350.
45. De Dooy JJ, Mahieu LM, Van Bever HP: The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001; 160: 457-463.
46. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E: Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1,000 g or less. J Pediatr 1996; 128: 470-478.
47. Edwards AD, Tan S: Perinatal infections, prematurity and brain injury. Curr Opin Pediatr 2006; 18: 119-124.
48. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J, Al-Nakib L, Rutherford MA, Battin M, Roberts I, Edwards AD: Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358: 1699-1700.